Patent Grant
12133877
The present invention relates generally to medical treatment compositions, and more particularly to a medical treatment composition, a method for its preparation, and a method for medical treatment by administering the composition.
Cancer treatments are the subject of extensive research and development. In spite of much focus and monetary investment on the part of pharmaceutical and biotechnology companies, it appears that no cure for cancer has yet been developed. Treatments exist which require a weighing of the treatment risk against the potential benefits the receiving the treatments.
Options appear to include natural pharmaceutical compositions, which have not resulted in an effective treatment or a cure.
For example, one option appears to pertain to a natural pharmaceutical composition, a preparation method thereof and application thereof in preparation of toxicity reducing and efficacy enhancing drugs for cancer chemotherapy. The natural pharmaceutical composition consists of a decoction concentrated extract of Andrographis paniculata (Burm.f.) Nees and Piper longum I., andrographolide, an ethanol extract of Piper longum I. and piperine which are in the ratio of (2-3):(6-9):(5-8):(1-5). The composition is alleged to provide an excellent treatment effect on cancer-chemotherapy-related diarrhea and can simultaneously play a synergic role in cancer chemotherapy. The option has not resulted in a cure, and has not been adopted for widespread use.
Another option appears to pertain to a natural drug extract. Said natural drug extract consists of an extract prepared by decocting and concentrating common andrographis herb and Clove in water, common andrographis herb lactone extract, Clove ethanol extract and eugenol by a ratio of (4-6):(3-6):(2-4):(6-9). The composition is alleged to have an extremely good treatment effect on diarrhea related with cancer chemotherapy and also has a synergism effect on cancer chemotherapy. The option has not resulted in a cure, and has not been adopted for widespread use.
Yet another option appears to pertain to a natural medicine composition and a preparation method thereof. The natural medicine composition is composed of an extract from Fructus schisandrae chinensis and Cloves by decoction with water and concentration, Fructus schisandrae chinensis polysaccharides, an extract from Cloves with ethyl alcohol, and eugenol according to the ratio of (2-4) to (3-5) to (3-8) to (5-8). The composition alleges to have a curative effect on cancer chemotherapy induced diarrhea. However, the option has not resulted in a cure, and has not been adopted for widespread use.
A method exists for preparing a potential herbal anti-cancer medicine from the leaves and twigs of Calotropis gigantean for prevention and treatment of all types of cancers, using fresh extract of leaves and twigs of Calotropis gigantea fortified with unrefined sugarcane sugar (jaggery). The method includes desiccating an aqueous extract of leaves and twigs of Calotropis gigantea. A [3 H]-Thymidine growth assay was performed against cancer cell lines, WM 902-B and WM1341-D. The extract [28 mgms] was dissolved in 2 ml control at 0.5%, 0.1% DMSO. The extract is alleged to be highly inhibitory at all dilutions to and highly inhibitory to cancer cell lines cancer cell lines, WM 902-B and WM1341-D. However, the option has not resulted in a cure, and has not been adopted for widespread use.
Accordingly, there remains a need for a solution to the problem of cancer treatment and cure.
The present invention is directed to a medical treatment compositions for treating and curing cancer, to a method for its preparation, and a method for providing cancer treatment by administering the composition.
In a one implementation of the invention, a composition for cancer prevention and treatment comprises Sansevieria and Cloves. The present invention is capable of preventing and healing cancer.
According to the website Garden-Care.org. UK, in addition to aesthetic features, Sansevieria plants may beneficially filter indoor air; remove toxic pollutants; combat airborne allergens; combat minor ailments; help boost mental health; be easily cared for; and help enhance the “energy” of a space, according to feng shui. 7 Benefits Of Keeping Snake Plants In Your Home; Moreover, certain species are recognized by NASA as being capable of purifying air by removing some pollutants such as formaldehyde, xylene, and toluene. Wolverton, B. C.; Johnson, Anne; Bounds, Keith (15 Sep. 1989). “Interior Landscape Plants for Indoor Air Pollution Abatement” (PDF). NASA.
It is commonly known that Sansevieria plants are recognized to be toxic if ingested.
Clove essential oil may be used to inhibit mold growth on some foods. Cloves are used in traditional medicine as the essential oil, which is used as an analgesic for dental emergencies. There is evidence that Clove oil containing eugenol is effective for toothache pain and other types of pain, and one review reported efficacy of eugenol combined with zinc oxide as an analgesic for alveolar osteitis. Clove essential oil may prevent the growth of Enterococcus faecalis bacteria which is often present in a root canal treatment failure.
Use of Clove for any medicinal purpose has not been approved by the US Food and Drug Administration, and its use may cause adverse effects if taken orally by people with liver disease, blood clotting and immune system disorders, or food allergies.
The potential use of Clove and Sansevieria for cancer prevention and anticancer treatments is antithetical to present teachings. The present invention provides an unprecedented solution to these important problems, is able to be used to prevent cancer, and to heal and improve the quality of life for people who have been diagnosed with cancer.
The mechanism by which these components may prevent and heal cancer appears to be related to the synergistic composition of the present invention.
In one aspect, the present invention provides a liquid composition comprising a predetermined amount of Sansevieria and a predetermined amount of Cloves.
In one aspect, the present invention provides a liquid composition comprising equal parts Sansevieria and blended Cloves.
In one aspect, the present invention provides a liquid composition comprising by volume 50% of a Sansevieria component and 50% of a Clove component.
In one aspect the present invention provides a liquid composition comprising 100 g. of Sansevieria and 100 g. of blended Cloves.
In another implementation, the present invention provides a method of preparing a medical treatment composition, the method comprising:
In one aspect, the method may further comprise providing a container or bottle with a cap or cover, removing the cap or cover from the container or bottle, adding the medical treatment composition to the container or bottle and replacing the cap or cover. In a further aspect, the composition may be stored at room temperature. In another aspect, the composition may be stored refrigerated. In a still further aspect, at least one dosage of the composition may be stored refrigerated.
In an additional implementation, the present invention provides a method for treating a medical condition, comprising:
In one aspect, the present invention provides a method for preventing or treating a medical condition comprising:
In one aspect, administering the liquid composition comprises ingesting a predetermined quantity of the liquid composition daily.
In one aspect, the medical condition comprises cancer.
In one aspect, the present invention provides a method of preventing or treating a medical condition wherein the liquid composition comprises equal parts Sansevieria and blended Cloves.
In one aspect, the present invention provides a method of preventing or treating a medical condition wherein the liquid composition comprises by volume 50% of a Sansevieria component and 50% of a Clove component.
In one aspect, the present invention provides a method of preventing or treating a medical condition wherein the liquid composition comprises 100 g. Sansevieria and 100 g. blended Cloves.
In another aspect, the medical disease may be any currently known or newly identified medical disease or condition.
In a further aspect, the medical disease or condition is cancer.
In one aspect, the method further comprises precluding use of the composition by pregnant women, or by women during their menstrual cycle, as the composition may cause hemorrhaging.
In one aspect, the method for preventing or treating a cancer further comprises administering the liquid composition with another supplemental medical treatment. In a further aspect, the supplemental medical treatment comprises a pharmaceutical drug. In a still further aspect, the supplemental medical treatment comprises chemotherapy. In a yet further aspect, the supplemental medical treatment comprises radiation.
In one aspect, the method further comprises administering the medical having cancer radiation treatments at the discretion of a primary physician.
In an additional implementation, the present invention provides a method for pest control. The method comprises providing a concentrate of a liquid composition which comprises equal parts Sansevieria and blended Cloves.
In one aspect, the method may further comprise providing a container operably connected with a spray dispenser; mixing the concentrate in the container with a solvent selected from water or alcohol to provide a pest control solution; and applying the pest control solution as needed to an area to be treated.
In one aspect, the present invention provides a method for exterminating termites, and the area to be treated comprises a surface or a structure upon which at least one termite has been detected, or a surface or structure whereupon termites may be expected to be located. In another aspect, the surface or structure may be made of wood, a wood-containing material, or a corrugated material. In another aspect, the termites are drywood termites.
These and other objects, features, and advantages of the present invention will become more readily apparent from the attached drawings and the detailed description of the preferred embodiments, which follow.
The preferred embodiments of the invention will hereinafter be described in conjunction with the appended drawings provided to illustrate and not to limit the invention, where like designations denote like elements, and in which:
Like reference numerals refer to like parts throughout the several views of the drawings.
The following detailed description is merely exemplary in nature and is not intended to limit the described embodiments or the application and uses of the described embodiments. As used herein, the word “exemplary” or “illustrative” means “serving as an example, instance, or illustration.” Any implementation described herein as “exemplary” or “illustrative” is not necessarily to be construed as preferred or advantageous over other implementations. All of the implementations described below are exemplary implementations provided to enable persons skilled in the art to make or use the embodiments of the disclosure and are not intended to limit the scope of the disclosure, which is defined by the claims. For purposes of description herein, the terms “upper”, “lower”, “left”, “rear”, “right”, “front”, “vertical”, “horizontal”, and derivatives thereof shall relate to the invention as oriented in
The present invention is directed to medical treatment compositions for treating and curing cancer. Shown throughout the figures, the present invention is further directed to methods for preparing the medical treatment compositions and for providing cancer treatment by administering the compositions.
In a first implementation, the present invention provides a medical treatment composition which comprises Sansevieria and Cloves. The composition may comprise a liquid composition further comprising a predetermined amount of Sansevieria and a predetermined amount of Cloves. In some embodiments, the liquid composition comprises equal parts Sansevieria and blended Cloves.
The liquid composition may comprise by volume 50% of a Sansevieria component and 50% of a Clove component.
In some embodiments, the present invention provides a liquid composition comprising 100 g. of Sansevieria and 100 g. of blended Cloves.
The medical treatment composition may be prepared by a method including one or more of the following steps and combinations thereof.
The methods of preparing the medical treatment composition may comprise providing components in the same proportions. Nonlimiting examples include providing 50 g. of Sansevieria and 250 mL of water; 50 g. of Clove, and 250 mL of solvent; or providing 200 g. of Sansevieria and 1000 mL of water, 200 g. of Clove, and 1000 mL of solvent.
The method may further comprise providing a container or bottle with a cap or cover, removing the cap or cover from the container or bottle, adding the medical treatment composition to the container or bottle and replacing the cap or cover.
The composition may be stored at room temperature. Alternatively, the composition may be stored refrigerated.
Further, the composition may be stored refrigerated in at least one dosage. For example without limitation, the at least one dosage may be stored refrigerated in at least one container, such as at least one recloseable or resealable container, or at least one sealed container.
Referring to
Referring to
Referring to
Referring now to
Referring now to
Referring now to
Referring now to
Referring now to
Referring now to
In a third implementation, the composition may be retained and stored in a bottle or container having a cap or cover. As shown at
In a fourth implementation, the present invention provides a method for treating a medical condition. The method may comprise providing a liquid composition comprising Sansevieria and blended Cloves and administering the liquid composition. In some embodiments, the liquid composition may comprise equal parts Sansevieria and blended Cloves. In some embodiments, the liquid composition may comprise by volume 50% of a Sansevieria component and 50% of a Clove component. In some embodiments, the liquid composition may comprise 100 g. Sansevieria and 100 g. blended Cloves.
The method further comprises administering or ingesting a predetermined quantity of the liquid composition daily.
In some embodiments, the medical condition comprises cancer.
The method for preventing or treating a cancer may further comprise administering the liquid composition with an additional or supplemental medical treatment. The additional or supplemental medical treatment may be any medical treatment. In some embodiments, the supplemental medical treatment comprises a pharmaceutical drug. Other nonlimiting examples of the additional or supplemental medical treatment may comprise chemotherapy, radiation or the like. For example without limitation, the method may further comprise administering at least one cancer radiation treatment or a plurality of cancer radiation treatments at the discretion of a primary physician or a physician specialist in oncology.
Further, the additional or supplemental medical treatment may comprise any alternative medicine therapy or natural treatment.
In some embodiments, the method further comprises precluding use of the composition by pregnant women, or by women during their menstrual cycle, as the composition may cause hemorrhaging.
Referring now to
The antacid composition may be any suitable antacid composition, such as over-the-counter antacid products, or the like.
In a fifth implementation, the present invention provides a method for providing a concentrate of a liquid composition which comprises equal parts Sansevieria and blended Cloves. The method may include any method steps described herein.
Referring now to
The composition concentrate may include a Sansevieria component having a smaller proportion of the water solvent. For example without limitation, a Sansevieria component made from about 100 g. of Sansevieria may include about 25%-99% of the water (i.e. 25-99% of 500 mL, or between about 125 mL-495 mL). Further, the composition concentrate may include a Clove component having a smaller proportion of solvent comprising water, 91% alcohol solvent or a combination thereof. For example without limitation, a Clove component made from about 100 g. of Clove may include about 25%-99% of the solvent (i.e., 25-99% of the 500 mL of the solvent or between about 125 mL-495 mL). Before use, the concentrate may be “reconstituted” by the addition of a volume of the Sansevieria component water solvent and the Clove component solvent comprising water, 91% alcohol or a combination thereof—which for a concentrate that includes 100 g. of Sansevieria, and 100 g. of Clove would be reconstituted to a volume of 1000 mL (1 L).
According to a sixth implementation, the present invention may also provide a method for pest control. The method may comprise providing and reconstituting a concentrate as shown at
Referring now to
In a seventh implementation, the pest control composition may be retained and stored in a bottle or container operably connected with a spray dispenser. As shown at
Referring now to
In some embodiments, the method is employed for exterminating termites, and the area to be treated comprises a surface or a structure upon which at least one termite has been detected, or a surface or structure whereupon termites may be expected to be located. The surface or structure may be made of wood, a wood-containing material, or a corrugated material. In some embodiments, the termites may be drywood termites.
Since many modifications, variations, and changes in detail can be made to the described preferred embodiments of the invention, it is intended that all matters in the foregoing description and shown in the accompanying drawings be interpreted as illustrative and not in a limiting sense. Thus, the scope of the invention should be determined by the appended claims and their legal equivalents.
| Number | Name | Date | Kind |
|---|---|---|---|
| 20040156920 | Kane | Aug 2004 | A1 |
| 20100303938 | Zacharia | Dec 2010 | A1 |
| 20190008907 | Al-Waili | Jan 2019 | A1 |
| Number | Date | Country |
|---|---|---|
| 1943649 | Apr 2007 | CN |
| 103191201 | Jul 2013 | CN |
| 103340929 | Oct 2013 | CN |
| 103655720 | Mar 2014 | CN |
| 113966807 | Jan 2022 | CN |
